Hyperamylasaemia in a patient with multiple myeloma in haemodialysis
Hiperamilasemia en un paciente con mieloma múltiple en hemodiálisis
Read
6640
Timeswas read the article
2018
Total PDF
4622
Total HTML
Share statistics
array:20 [ "pii" => "X2013251409005217" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.1.93.1.en.full.pdf" "estado" => "S300" "fechaPublicacion" => "2009-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:93-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2851 "formatos" => array:3 [ "EPUB" => 217 "HTML" => 2221 "PDF" => 413 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X021169950900521X" "issn" => "02116995" "doi" => "10.3265/Nefrologia.2009.29.1.93.1.en.full.pdf" "estado" => "S300" "fechaPublicacion" => "2009-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2009;29:93-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 9471 "formatos" => array:3 [ "EPUB" => 264 "HTML" => 8619 "PDF" => 588 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Hiperamilasemia en un paciente con mieloma múltiple en hemodiálisis" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "93" "paginaFinal" => "94" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Hyperamylasaemia in a patient with multiple myeloma in haemodialysis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Florencio García Martín, Ana Huerta Arroyo, José María Alcázar de la Ossa, Manuel Praga Terente" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Florencio" "apellidos" => "García Martín" ] 1 => array:2 [ "nombre" => "Ana" "apellidos" => "Huerta Arroyo" ] 2 => array:2 [ "nombre" => "José María" "apellidos" => "Alcázar de la Ossa" ] 3 => array:2 [ "nombre" => "Manuel" "apellidos" => "Praga Terente" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251409005217" "doi" => "10.3265/Nefrologia.2009.29.1.93.1.en.full.pdf" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409005217?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950900521X?idApp=UINPBA000064" "url" => "/02116995/0000002900000001/v0_201502091413/X021169950900521X/v0_201502091414/es/main.assets" ] ] "itemAnterior" => array:17 [ "pii" => "X2013251409005241" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.1.92.1.en.full.pdf" "estado" => "S300" "fechaPublicacion" => "2009-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:92" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3183 "formatos" => array:3 [ "EPUB" => 227 "HTML" => 2586 "PDF" => 370 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Nephropathy induced by BKV or co-infection?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "92" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "¿NEFROPATIA POR VBK O COINFECCION?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carla Ferreyra Lanatta, José Manuel Osorio, Juan Bravo, Antonio Osuna" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Carla" "apellidos" => "Ferreyra Lanatta" ] 1 => array:2 [ "nombre" => "José Manuel" "apellidos" => "Osorio" ] 2 => array:2 [ "nombre" => "Juan" "apellidos" => "Bravo" ] 3 => array:2 [ "nombre" => "Antonio" "apellidos" => "Osuna" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699509005244" "doi" => "10.3265/Nefrologia.2009.29.1.92.1.en.full.pdf" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509005244?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409005241?idApp=UINPBA000064" "url" => "/20132514/0000002900000001/v0_201502091632/X2013251409005241/v0_201502091633/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Hyperamylasaemia in a patient with multiple myeloma in haemodialysis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "93" "paginaFinal" => "94" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Florencio García Martín, Ana Huerta Arroyo, José María Alcázar de la Ossa, Manuel Praga Terente" "autores" => array:4 [ 0 => array:3 [ "nombre" => "Florencio" "apellidos" => "García Martín" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "Ana" "apellidos" => "Huerta Arroyo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 2 => array:3 [ "nombre" => "José María" "apellidos" => "Alcázar de la Ossa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 3 => array:3 [ "nombre" => "Manuel" "apellidos" => "Praga Terente" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Servicio de Nefología, Hospital 12 de Octubre, Madrid, Madrid, España, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hiperamilasemia en un paciente con mieloma múltiple en hemodiálisis" ] ] "textoCompleto" => "<p class="elsevierStylePara">Dear Editor,</p><p class="elsevierStylePara">An increase in amylase is a marker for acute pancreatitis. However in patients with Chronic Renal Failure (CRF) it is not uncommon to find increased levels, yet these rarely exceed two or three times the maximum normal limit.<span class="elsevierStyleSup">1</span></p><p class="elsevierStylePara">The link between hyperamylasaemia and neoplasia has been known for years and has been described in tumours of different histological strains<span class="elsevierStyleSup">2</span> and in multiple myeloma also.<span class="elsevierStyleSup">3,4</span>We present a patient Figure 1. Resolution of calciphylaxis. with CRF secondary to myeloma kidney in periodic haemodialysis (HD) who presented with hyperamylasaemia and rapid evolution of their disease.</p><p class="elsevierStylePara">77 year old male patient diagnosed with Lambda light chain-associated multiple myeloma in November 2002. At this time he presented with creatinine 2.8mg/dl and Bence Jones proteinuria. The patient received different lines of treatment (vincristine-adriamycin-dexamethasone; melphalan-prednisone; bortezomib) with clinical responses that were increasingly poorer. Administration of chemotherapy drugs was discontinued two years later. In July 2004, the patient started HD treatment, 12 hours a week with an average Kt/v of > 1.2. Residual diuresis was maintained at 700-1000cc/day.</p><p class="elsevierStylePara">The patient was admitted in November 2007 due to the deterioration of his general health with intense asthenia, epigastrium pain and significant bone pain with difficulties in deambulation. Physical examination found BP 140/80mmHg, no fever, pale skin and mucosa and without any other significant findings. Blood tests: Hb 7.9g/dl; hematocrit 23.3%; platelets 56,000/mm;<span class="elsevierStyleSup">3</span> leukocytes 6000/mm<span class="elsevierStyleSup">3</span> with normal formula. ESR 84 mm during the first hour; no schistocytes or blastos were observed in the peripheral blood. Iron 93μg/dl; ferritin 6603ng/ml; transferrin saturation rate 45%. Creatinine 7.91; urea 130; Ca 9.30; P 2; uric acid 7.5 (mg/dl); total proteins 6.50; albumin 3.32g/dl; IgG 370; IgA 43; IgM 15; IgD 1 (mg/dl.) Serum immunofixation: Lambda monoclonal band. C-reactive protein 13.8mg/dl. GOT 56; GPT 33; GGT 480; alkaline phosphatase 139, LDH 780, amylase 3779; lipase 449 (IU/L.) Two months before, amylase levels were normal. Amylasuria 276 IU/L, with urinary excretion of amylase 6%.</p><p class="elsevierStylePara">Ultrasound and abdominal Computerised Axial Tomography (CAT) did not show findings of pancreatic disease. Due to the persistence of hyperamylasaemia, the pancreatic enzymes were studied: pancreatic isozyme 132; salivary isozyme 3607 IU/l. In light of the patient’s general condition, treatment was started with high doses of steroids and morphine chloride with the aim of decompressing the bone marrow and alleviating pain in the bones, which were increasing. The clinical situation worsened and the patient died 10 days after admission.</p><p class="elsevierStylePara">Acute pancreatitis is the first diagnosis suspect with respect to an acute increase in amylase levels. Its incidence in CRF is six times greater than in the general population.<span class="elsevierStyleSup">5</span> Hypercalcaemia, hyperparathyroidism, dyslipidaemia and treatment with diuretics are predisposing factors. In HD, cases of pancreatitis associated with haemolysis have also been described.<span class="elsevierStyleSup">6</span> In the present case, the clinical picture and the abdominal CAT ruled out acute pancreatitis.<br></br><br></br>Macroamylasaemia is a biochemical abnormality of unknown aetiology. It is characterised by the presence of amylase complexes attached to proteins, which form a molecule with greater molecular weight, which accumulate in the plasma, since filtration decreases.<span class="elsevierStyleSup">7</span> Amylase levels are normally lower than two times the normal limit. Diagnosis is established by determining the molecular weight of the serum amylase, with immunological techniques, and indirectly, by determining the fractional excretion of amylase in the urine. Avalue < 1% is indicative of macroamylasaemia. The absence of monoclonal peak in the blood and urinary excretion of amylase of 6% exclude this diagnosis.</p><p class="elsevierStylePara">Paraneoplastic hyperamylasaemia is a rare manifestation of multiple myeloma. A total of 21 cases have been described with an average age of 66. It is more commonly associated with the IgA type (40%), followed by IgG (30%) and it has only been described in two patients with light chain myeloma.<span class="elsevierStyleSup">3,4</span> The lambda light chain isotype predominates in proportions of 3:1 in comparison with the kappa type and amylase detected in all saliva originating cases. It is the tumour cells that cause the ectopic segregation of salivary amylase and the secretion mechanism is similar to that of immunoglobulins.<span class="elsevierStyleSup">8</span> It has been seen in patients with hyperamylasaemia the myeloma is more aggressive, it has greater extramedullary extension, a poorer response to chemotherapy treatment and therefore lower survival rate (< 24 months.) Amylase in the myeloma has been used as a marker for progression and response to treatment.</p><p class="elsevierStylePara">Although the incidence of acute pancreatitis in patients with CRF is high, the appearance of hyperamylasaemia of salivary origin forces to considering paraneoplastic origin.</p>" "pdfFichero" => "P-E-S-A247-EN.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Robitaille R, Lafrance JP, Leblanc M. Altered laboratory findings associated with End-Stage Renal Disease. Semin Dial 2006; 19:373-380. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16970737" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Yamazaki S, Ebisawa S, Yasuo M, Urushihata K, Koizumi T, Fujimoto K, Kubo K. Smal-cell lung carcinoma produces salivary-type amylase: a case report with review. Intern Med 2007;46:883-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17575383" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ross CM, Devgun MS, Gunn IR. Hyperamylasaemia and multiple myeloma. Ann Clin Biochem 2002; 39:616- 620. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12564849" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Calvo-Villas JM, Alvarez I, Carretera E, Espinosa J, Sicilia F. Paraneoplastic hyperamylasaemia in association with multiple myeloma. Acta Haematol 2007;117:242-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17377372" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Padilla B, Pollak VE, Pesce A, Kant KS, Gilinsky NH, Deddens JA. Pancreatitis in patients with end-stage renal disease. Medicine (Baltimore) 1994;73:8-20." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Pascual-Capdevila J, Ara J, Mirapeix E, Torras A, Darnell A y Revert L. Hemólisis y pancreatitis en el curso de una hemodiálisis. Nefrologia 1997;17:257-260." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Tietz NW, Huang WY, Rauh DF, Shuey DF. Laboratory tests in the differential diagnosis of hyperamylasemia. Clin Chem 1986;32:301-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2417752" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:1 [ "itemHostRev" => array:3 [ "pii" => "S0016508509008683" "estado" => "S300" "issn" => "00165085" ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Shigemura M, Moriyama T, Shibuya H, Obara M, Endo T, Hashino S, Yokouchi H, Asaka M, Shimizu C, Chiba H, Nishimura M. Multiple myeloma associated with sialyl salivary-type amylase. Clin Chim Acta 2007;376:121-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16979610" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000002900000001/v0_201502091632/X2013251409005217/v0_201502091633/en/main.assets" "Apartado" => array:4 [ "identificador" => "35436" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002900000001/v0_201502091632/X2013251409005217/v0_201502091633/en/P-E-S-A247-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409005217?idApp=UINPBA000064" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 10 | 9 | 19 |
| 2024 October | 40 | 33 | 73 |
| 2024 September | 45 | 24 | 69 |
| 2024 August | 61 | 59 | 120 |
| 2024 July | 39 | 61 | 100 |
| 2024 June | 52 | 43 | 95 |
| 2024 May | 68 | 32 | 100 |
| 2024 April | 44 | 27 | 71 |
| 2024 March | 27 | 26 | 53 |
| 2024 February | 42 | 38 | 80 |
| 2024 January | 27 | 22 | 49 |
| 2023 December | 19 | 23 | 42 |
| 2023 November | 59 | 28 | 87 |
| 2023 October | 39 | 27 | 66 |
| 2023 September | 54 | 31 | 85 |
| 2023 August | 47 | 22 | 69 |
| 2023 July | 40 | 25 | 65 |
| 2023 June | 33 | 19 | 52 |
| 2023 May | 32 | 26 | 58 |
| 2023 April | 26 | 15 | 41 |
| 2023 March | 39 | 34 | 73 |
| 2023 February | 32 | 13 | 45 |
| 2023 January | 43 | 22 | 65 |
| 2022 December | 46 | 31 | 77 |
| 2022 November | 45 | 26 | 71 |
| 2022 October | 57 | 38 | 95 |
| 2022 September | 42 | 30 | 72 |
| 2022 August | 39 | 36 | 75 |
| 2022 July | 32 | 39 | 71 |
| 2022 June | 37 | 17 | 54 |
| 2022 May | 44 | 39 | 83 |
| 2022 April | 45 | 39 | 84 |
| 2022 March | 41 | 44 | 85 |
| 2022 February | 68 | 38 | 106 |
| 2022 January | 45 | 30 | 75 |
| 2021 December | 32 | 53 | 85 |
| 2021 November | 58 | 46 | 104 |
| 2021 October | 52 | 40 | 92 |
| 2021 September | 54 | 44 | 98 |
| 2021 August | 55 | 29 | 84 |
| 2021 July | 56 | 46 | 102 |
| 2021 June | 60 | 53 | 113 |
| 2021 May | 37 | 21 | 58 |
| 2021 April | 44 | 23 | 67 |
| 2021 March | 88 | 40 | 128 |
| 2021 February | 61 | 19 | 80 |
| 2021 January | 36 | 19 | 55 |
| 2020 December | 30 | 16 | 46 |
| 2020 November | 22 | 9 | 31 |
| 2020 October | 26 | 16 | 42 |
| 2020 September | 26 | 7 | 33 |
| 2020 August | 31 | 5 | 36 |
| 2020 July | 35 | 9 | 44 |
| 2020 June | 31 | 8 | 39 |
| 2020 May | 32 | 9 | 41 |
| 2020 April | 29 | 16 | 45 |
| 2020 March | 28 | 9 | 37 |
| 2020 February | 37 | 13 | 50 |
| 2020 January | 41 | 32 | 73 |
| 2019 December | 34 | 13 | 47 |
| 2019 November | 25 | 23 | 48 |
| 2019 October | 11 | 7 | 18 |
| 2019 September | 18 | 13 | 31 |
| 2019 August | 10 | 10 | 20 |
| 2019 July | 26 | 18 | 44 |
| 2019 June | 17 | 2 | 19 |
| 2019 May | 11 | 2 | 13 |
| 2019 April | 23 | 28 | 51 |
| 2019 March | 17 | 14 | 31 |
| 2019 February | 6 | 13 | 19 |
| 2019 January | 19 | 11 | 30 |
| 2018 December | 33 | 21 | 54 |
| 2018 November | 57 | 10 | 67 |
| 2018 October | 64 | 14 | 78 |
| 2018 September | 44 | 9 | 53 |
| 2018 August | 18 | 11 | 29 |
| 2018 July | 21 | 8 | 29 |
| 2018 June | 21 | 9 | 30 |
| 2018 May | 17 | 12 | 29 |
| 2018 April | 30 | 5 | 35 |
| 2018 March | 28 | 7 | 35 |
| 2018 February | 22 | 3 | 25 |
| 2018 January | 22 | 6 | 28 |
| 2017 December | 26 | 9 | 35 |
| 2017 November | 32 | 2 | 34 |
| 2017 October | 26 | 7 | 33 |
| 2017 September | 20 | 11 | 31 |
| 2017 August | 20 | 7 | 27 |
| 2017 July | 22 | 14 | 36 |
| 2017 June | 16 | 6 | 22 |
| 2017 May | 15 | 5 | 20 |
| 2017 April | 18 | 4 | 22 |
| 2017 March | 11 | 1 | 12 |
| 2017 February | 10 | 3 | 13 |
| 2017 January | 8 | 6 | 14 |
| 2016 December | 27 | 6 | 33 |
| 2016 November | 44 | 7 | 51 |
| 2016 October | 57 | 2 | 59 |
| 2016 September | 67 | 4 | 71 |
| 2016 August | 117 | 3 | 120 |
| 2016 July | 95 | 4 | 99 |
| 2016 June | 90 | 0 | 90 |
| 2016 May | 106 | 0 | 106 |
| 2016 April | 67 | 0 | 67 |
| 2016 March | 60 | 0 | 60 |
| 2016 February | 69 | 0 | 69 |
| 2016 January | 72 | 0 | 72 |
| 2015 December | 90 | 0 | 90 |
| 2015 November | 63 | 0 | 63 |
| 2015 October | 60 | 0 | 60 |
| 2015 September | 70 | 0 | 70 |
| 2015 August | 54 | 0 | 54 |
| 2015 July | 53 | 0 | 53 |
| 2015 June | 24 | 0 | 24 |
| 2015 May | 54 | 0 | 54 |
| 2015 April | 5 | 0 | 5 |
Show all
